Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wyeth is now a wholly owned subsidiary of Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women subjects aged 18 years or older.
Current outpatient treatment with extended-release venlafaxine HCl (U.S. marketed brand Effexor XR®), within the US Food and Drug Administration (FDA)-approved dosage range for depression (37.5 mg/day to 225 mg/day), for 8 weeks or less.
Ability to have a blood draw within 4 to 12 hours of the most recent dose of Effexor XR®.
You may not be if
Determination by the investigator that a blood draw is contraindicated.
Participation in an investigational study within the past 30 days where the study medication is not known.
Previous treatment with Effexor XR® or extended-release venlafaxine HCl (generic) in the 6 months prior to current treatment regimen.
Treatment with DVS SR within the last 30 days.
Clareo Health | Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl
